CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
16 juil. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
19 juin 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth...
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
14 mai 2019 09h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has closed on the previously...
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
02 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and...
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
26 mars 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has successfully completed a pre-IND...
Fuisz Pharma LLC Announces Notice of Patent Allowance for its System of Custody and Control for Abusable Drugs: Blockchain like HIPPA Compliant Technology Applies Custody and Control Parameters to Unit Dose Packaged Drugs
09 nov. 2018 07h45 HE
|
Fuisz Pharma LLC
Miami, FL, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today that it has received a Notice of Allowance from the United States Patent Office in connection with its patent...
Fuisz Pharma LLC Announces Allowance of Additional Patent Claims for its New Film by Deposit Technology Platform
08 oct. 2018 07h45 HE
|
Fuisz Pharma LLC
Miami, FL, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz) announced today the allowance of additional patent claims for its Film by Deposit Technology Platform. Fuisz previously...
Update: Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent (re-release)
05 mars 2018 10h30 HE
|
Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film...
Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent
05 mars 2018 07h30 HE
|
Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film...
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
03 oct. 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed...